シンボル | 取引所 | 通貨 | ||
---|---|---|---|---|
AMGN | ナスダック | USD | リアルタイム | |
AMGN | メキシコ | MXN | 遅れた | |
AMGN | BIVA | MXN | 遅れた | |
AAMGN | ミラノ | EUR | リアルタイム | |
AMGN | TradeGate | EUR | 遅れた | |
AMGN | Xetra | EUR | 遅れた | |
AMGN | フランクフルト | EUR | 遅れた | |
AMGNm | ブエノスアイレス | ARS | 遅れた | |
AMGN34 | B3 | BRL | 遅れた | |
AMGN | ウィーン | EUR | リアルタイム | |
AMGN | リマ | USD | 遅れた |
アムジェン(Amgen Inc.)はバイオテクノロジー会社である。【事業内容】同社は多様なヒト治療法を発見・開発・製造・提供する。同社はヒト治療事業を運営する。同社の製品ポートフォリオはNeulasta(ペグフィルグラスチム)、Aranesp(ダルベポエチンアルファ)・EPOGEN(エポエチンアルファ)等の赤血球産生促進剤(ESAs)、Sensipar/Mimpara(シナカルセット)、XGEVA(デノスマブ)、Prolia(デノスマブ)及びNEUPOGEN(フィルグラスチム)、並びにKYPROLIS(カルミゾミブ)、Vectibix(パニツムマブ)、Nplate(ロムリプスチム)、Repatha(エボロクマブ)、BLINCYTO(ブリナトモマブ)、IMLYGIC(タルミモジュラーラパーパープ)、Corlanor(イバブラジン)など他の市販製品を含む。同社は腫瘍/血液学、心臓血管疾患および神経科学の分野における重篤な疾患の治療のためのヒト治療法を提供し、反復性片頭痛治療用Erenumab、骨髄異形成症候群治療用Aranesp、急性リンパ芽球性白血病治療用BLINCYTOおよび転移性メラノーマ治療用IMLYGICを含むフェーズⅢの製品候補を提供する。
銘柄 | 年齢 | 以来 | タイトル |
---|---|---|---|
Robert A. Bradway | 58 | 2007 | Chairman, CEO & President |
Tyler E. Jacks | 62 | 2012 | Independent Director |
David Baltimore | 85 | 1999 | Co-Chair of Scientific Advisory Board |
Charles M. Holley | 66 | 2017 | Independent Director |
Charles Elliott Sigal | 72 | - | Co-Chair of the Scientific Advisory Board |
Ellen J. Kullman | 68 | 2016 | Independent Director |
Robert A. Eckert | 70 | 2012 | Lead Independent Director |
Amy E. Miles | 57 | 2020 | Independent Director |
Wanda M. Austin | 70 | 2017 | Independent Director |
Greg C. Garland | 67 | 2013 | Independent Director |
Brian J. Druker | 68 | 2018 | Independent Director |
S. Omar Ishrak | 68 | 2021 | Independent Director |
Benoit Van den Eynde | - | - | Member of Scientific Advisory Board of Oncology |
David J. Anderson | - | - | Member of Scientific Advisory Board of Research Trends & Emerging Technologies |
Diane J. Mathis | - | - | Member of Scientific Advisory Board of Inflammation |
Dean Sheppard | - | 2022 | Member of Scientific Advisory Board of Inflammation |
Alexander Rudensky | - | 2022 | Member of Scientific Advisory Board of Inflammation |
Alexander Marson | - | 2022 | Member of Scientific Advisory Board of Inflammation |
Arlene Sharpe | - | 2022 | Member of Scientific Advisory Board of Inflammation |
Ruslan Medzhitov | - | - | Member of Scientific Advisory Board of Research Trends & Emerging Technologies |
Antoni Ribas | 57 | - | Member of Scientific Advisory Board of Oncology |
Peter Libby | 77 | - | Member of Scientific Advisory Board of Cardiovascular & Metabolic |
Robert S. Negrin | - | - | Member of Scientific Advisory Board of Oncology |
Daniel P. Kelly | - | - | Member of Scientific Advisory Board of Cardiovascular & Metabolic |
Daniel Joshua Drucker | - | - | Member of Scientific Advisory Board of Cardiovascular & Metabolic |
Frank P. McCormick | 74 | - | Member of Scientific Advisory Board of Research Trends & Emerging Technologies |
Michael V. Drake | 73 | 2022 | Independent Director |
S. Gail Eckhardt | - | 2022 | Member of Scientific Advisory Board of Oncology |
Mary E. Klotman | - | 2024 | Director |
George Georgiou | 65 | 2023 | Member of Scientific Advisory Board of Research Trends & Emerging Technologies |
Richard O. Hynes | - | - | Member of Scientific Advisory Board of Research Trends & Emerging Technologies |
Emma Guttman-Yassky | - | 2022 | Member of Scientific Advisory Board of Inflammation |
Meilan Han | - | 2022 | Member of Scientific Advisory Board of Inflammation |
Marlene Rabinovitch | - | - | Member of Scientific Advisory Board of Cardiovascular & Metabolic |
David Alan Kass | - | - | Member of Scientific Advisory Board of Cardiovascular & Metabolic |
Jonathan S. Weissman | - | - | Member of Scientific Advisory Board of Research Trends & Emerging Technologies |
E. Dale Abel | - | - | Member of Scientific Advisory Board of Cardiovascular & Metabolic |
Lillian L. Siu | - | 2022 | Member of Scientific Advisory Board of Oncology |
Maria T. Abreu | - | 2022 | Member of Scientific Advisory Board of Inflammation |
John Kuriyan | - | - | Member of Scientific Advisory Board of Research Trends & Emerging Technologies |
Elizabeth McNally | - | - | Member of Scientific Advisory Board of Cardiovascular & Metabolic |
Jeffery D. Molkentin | - | - | Member of Scientific Advisory Board of Cardiovascular & Metabolic |
Siwen Hu-Lieskovan | - | - | Member of Scientific Advisory Board of Oncology |
Drew Mark Pardoll | - | - | Member of Scientific Advisory Board of Oncology |
Ronald M. Evans | 75 | - | Member of Scientific Advisory Board of Research Trends & Emerging Technologies |
Dirk Jäger | - | - | Member of Scientific Advisory Board of Oncology |
Robert Tjian | 75 | - | Member of Scientific Advisory Board Member of Research Trends & Emerging Technologies |
Thomas Quertermous | 72 | - | Member of Scientific Advisory Board of Cardiovascular & Metabolic |
Fabrice Andre | - | - | Member of Scientific Advisory Board of Oncology |
本当に%USER_NAME%をブロックしたいですか。
ブロックすると、あなたと%USER_NAME%はお互いのInvesting.comへの投稿を見ることができなくなります。
%USER_NAME%は無事ブロックリストに追加されました
この人のブロックを解除したばかりなので、再度ブロックするには48時間待つ必要があります。
このコメントについて下記のように感じます
ありがとうございます!
報告は、確認のため管理担当に送られました